184 related articles for article (PubMed ID: 27487387)
21. Frontiers of high-throughput metabolomics.
Zampieri M; Sekar K; Zamboni N; Sauer U
Curr Opin Chem Biol; 2017 Feb; 36():15-23. PubMed ID: 28064089
[TBL] [Abstract][Full Text] [Related]
22. An integrated Qual/Quan strategy for ganglioside lipidomics using high-resolution mass spectrometry and Skyline software.
Ranasinghe A; Ciccimaro E; D'Arienzo C; Olah TV; Ponath P; Hnatyshyn S
Rapid Commun Mass Spectrom; 2021 Apr; 35(7):e9041. PubMed ID: 33415785
[TBL] [Abstract][Full Text] [Related]
23. Software-aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery.
Cece-Esencan EN; Fontaine F; Plasencia G; Teppner M; Brink A; Pähler A; Zamora I
Rapid Commun Mass Spectrom; 2016 Jan; 30(2):301-10. PubMed ID: 26689160
[TBL] [Abstract][Full Text] [Related]
24. Mass spectrometry-based technologies for high-throughput metabolomics.
Han J; Datla R; Chan S; Borchers CH
Bioanalysis; 2009 Dec; 1(9):1665-84. PubMed ID: 21083110
[TBL] [Abstract][Full Text] [Related]
25. It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS.
Ramanathan R; Jemal M; Ramagiri S; Xia YQ; Humpreys WG; Olah T; Korfmacher WA
J Mass Spectrom; 2011 Jun; 46(6):595-601. PubMed ID: 21630388
[TBL] [Abstract][Full Text] [Related]
26. Introduction of a routine quan/qual approach into research DMPK: experiences and evolving strategies.
King L; Kotian A; Jairaj M
Bioanalysis; 2014; 6(24):3337-48. PubMed ID: 25534790
[TBL] [Abstract][Full Text] [Related]
27. Development of a lipid profiling system using reverse-phase liquid chromatography coupled to high-resolution mass spectrometry with rapid polarity switching and an automated lipid identification software.
Yamada T; Uchikata T; Sakamoto S; Yokoi Y; Fukusaki E; Bamba T
J Chromatogr A; 2013 May; 1292():211-8. PubMed ID: 23411146
[TBL] [Abstract][Full Text] [Related]
28. High-throughput bioanalysis of bile acids and their conjugates using UHPLC coupled to HRMS.
Ding J; Lund ET; Zulkoski J; Lindsay JP; McKenzie DL
Bioanalysis; 2013 Oct; 5(20):2481-94. PubMed ID: 24138622
[TBL] [Abstract][Full Text] [Related]
29. The application of ion mobility mass spectrometry to metabolomics.
Zhang X; Quinn K; Cruickshank-Quinn C; Reisdorph R; Reisdorph N
Curr Opin Chem Biol; 2018 Feb; 42():60-66. PubMed ID: 29161611
[TBL] [Abstract][Full Text] [Related]
30. Software automation tools for increased throughput metabolic soft-spot identification in early drug discovery.
Zelesky V; Schneider R; Janiszewski J; Zamora I; Ferguson J; Troutman M
Bioanalysis; 2013 May; 5(10):1165-79. PubMed ID: 23721441
[TBL] [Abstract][Full Text] [Related]
31. proFIA: a data preprocessing workflow for flow injection analysis coupled to high-resolution mass spectrometry.
Delabrière A; Hohenester UM; Colsch B; Junot C; Fenaille F; Thévenot EA
Bioinformatics; 2017 Dec; 33(23):3767-3775. PubMed ID: 29036359
[TBL] [Abstract][Full Text] [Related]
32. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis.
Rafiei A; Sleno L
Rapid Commun Mass Spectrom; 2015 Jan; 29(1):119-27. PubMed ID: 25462372
[TBL] [Abstract][Full Text] [Related]
33. Acoustic ejection mass spectrometry: fundamentals and applications in high-throughput drug discovery.
Liu C
Expert Opin Drug Discov; 2022 Jul; 17(7):775-787. PubMed ID: 35635049
[TBL] [Abstract][Full Text] [Related]
34. Updates in metabolomics tools and resources: 2014-2015.
Misra BB; van der Hooft JJ
Electrophoresis; 2016 Jan; 37(1):86-110. PubMed ID: 26464019
[TBL] [Abstract][Full Text] [Related]
35. Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS.
Ma S; Chowdhury SK
Bioanalysis; 2013 May; 5(10):1285-97. PubMed ID: 23721449
[TBL] [Abstract][Full Text] [Related]
36. Current status and future directions of high-throughput ADME screening in drug discovery.
Shou WZ
J Pharm Anal; 2020 Jun; 10(3):201-208. PubMed ID: 32612866
[TBL] [Abstract][Full Text] [Related]
37. Data processing for high-throughput mass spectrometry in drug discovery.
Liu C; Zhang H
Expert Opin Drug Discov; 2024 Jul; 19(7):815-825. PubMed ID: 38785418
[TBL] [Abstract][Full Text] [Related]
38. Integrated quantitative and qualitative workflow for in vivo bioanalytical support in drug discovery using hybrid Q-TOF-MS.
Ranasinghe A; Ramanathan R; Jemal M; D'Arienzo CJ; Humphreys WG; Olah TV
Bioanalysis; 2012 Mar; 4(5):511-28. PubMed ID: 22409550
[TBL] [Abstract][Full Text] [Related]
39. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
Xu R; Manuel M; Cramlett J; Kassel DB
J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
[TBL] [Abstract][Full Text] [Related]
40. Evaluation and validation of an analytical approach for high-throughput metabolomic fingerprinting using direct introduction-high-resolution mass spectrometry: Applicability to classification of urine of scrapie-infected ewes.
Rathahao-Paris E; Alves S; Boussaid N; Picard-Hagen N; Gayrard V; Toutain PL; Tabet JC; Rutledge DN; Paris A
Eur J Mass Spectrom (Chichester); 2019 Apr; 25(2):251-258. PubMed ID: 30335517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
